Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2025-12-25 @ 5:09 AM
NCT ID:
NCT04038827
Eligibility Criteria:
Inclusion Criteria:
* patients undergoing allo-HSCT for their neoplastic hematologic diseases
* written informed consent
* achievement of hematopoietic recovery from aplasia post-allo-HSCT
* predictable life expectancy \> 6 months
Exclusion Criteria:
* presence of active malignant hematologic disease at time of allo-HSCT
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04038827
Study Brief:
Protocol Section:
NCT04038827